ANIX
Price
$3.22
Change
-$0.16 (-4.73%)
Updated
Jun 27 closing price
Capitalization
103.08M
76 days until earnings call
GBIO
Price
$0.30
Change
-$0.06 (-16.67%)
Updated
Jun 27 closing price
Capitalization
22.46M
39 days until earnings call
Interact to see
Advertisement

ANIX vs GBIO

Header iconANIX vs GBIO Comparison
Open Charts ANIX vs GBIOBanner chart's image
Anixa Biosciences
Price$3.22
Change-$0.16 (-4.73%)
Volume$100.65K
Capitalization103.08M
Generation Bio
Price$0.30
Change-$0.06 (-16.67%)
Volume$7.39M
Capitalization22.46M
ANIX vs GBIO Comparison Chart in %
Loading...
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIX vs. GBIO commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIX is a StrongBuy and GBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (ANIX: $3.22 vs. GBIO: $0.30)
Brand notoriety: ANIX and GBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANIX: 75% vs. GBIO: 1118%
Market capitalization -- ANIX: $103.08M vs. GBIO: $22.46M
ANIX [@Biotechnology] is valued at $103.08M. GBIO’s [@Biotechnology] market capitalization is $22.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIX’s FA Score shows that 0 FA rating(s) are green whileGBIO’s FA Score has 0 green FA rating(s).

  • ANIX’s FA Score: 0 green, 5 red.
  • GBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, ANIX is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIX’s TA Score shows that 5 TA indicator(s) are bullish while GBIO’s TA Score has 3 bullish TA indicator(s).

  • ANIX’s TA Score: 5 bullish, 5 bearish.
  • GBIO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ANIX is a better buy in the short-term than GBIO.

Price Growth

ANIX (@Biotechnology) experienced а -4.73% price change this week, while GBIO (@Biotechnology) price change was -20.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ANIX is expected to report earnings on Sep 12, 2025.

GBIO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANIX($103M) has a higher market cap than GBIO($22.5M). ANIX YTD gains are higher at: 38.793 vs. GBIO (-71.660). ANIX has higher annual earnings (EBITDA): -13.11M vs. GBIO (-69.2M). GBIO has more cash in the bank: 158M vs. ANIX (15.6M). ANIX has less debt than GBIO: ANIX (221K) vs GBIO (87.6M). GBIO has higher revenues than ANIX: GBIO (24.6M) vs ANIX (0).
ANIXGBIOANIX / GBIO
Capitalization103M22.5M458%
EBITDA-13.11M-69.2M19%
Gain YTD38.793-71.660-54%
P/E RatioN/AN/A-
Revenue024.6M-
Total Cash15.6M158M10%
Total Debt221K87.6M0%
FUNDAMENTALS RATINGS
ANIX: Fundamental Ratings
ANIX
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
82
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANIXGBIO
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 19 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
85%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ANIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYG4.230.02
+0.48%
Lloyds Banking Group PLC
MTAL12.090.02
+0.17%
MAC Copper Limited
AB40.46-0.44
-1.08%
AllianceBernstein Holding LP
ATER1.62-0.04
-2.41%
Aterian
GNFT3.61-0.23
-5.99%
Genfit SA

ANIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIX has been loosely correlated with LGND. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIX jumps, then LGND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIX
1D Price
Change %
ANIX100%
-4.73%
LGND - ANIX
33%
Loosely correlated
-1.33%
KALV - ANIX
32%
Poorly correlated
-0.78%
FDMT - ANIX
32%
Poorly correlated
-5.65%
GBIO - ANIX
32%
Poorly correlated
-15.40%
REPL - ANIX
31%
Poorly correlated
-1.37%
More

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with CCCC. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
-15.40%
CCCC - GBIO
50%
Loosely correlated
-7.89%
ATXS - GBIO
50%
Loosely correlated
+2.39%
IDYA - GBIO
48%
Loosely correlated
-4.13%
IPSC - GBIO
48%
Loosely correlated
-8.62%
ATNM - GBIO
48%
Loosely correlated
-12.35%
More